Haemonetics Corporation (HAE)

Receivables turnover

		Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Revenue	US$ in thousands	1,360,820	1,309,060	1,168,660	993,196	870,463
Receivables	US$ in thousands	202,657	206,562	179,142	159,376	127,555
Receivables turnover		6.71	6.34	6.52	6.23	6.82

March 31, 2025 calculation

Receivables turnover = Revenue ÷ Receivables
= $1,360,820K ÷ $202,657K
= 6.71

Haemonetics Corporation's receivables turnover for the years ending March 31, 2021 to March 31, 2024, demonstrates a consistent range between 6.23 and 6.82. This indicates that, on average, the company collected its accounts receivable approximately 6 times over the course of those years.

The slight fluctuations in receivables turnover may be attributed to changes in the company's credit policies, customer payment behavior, or overall economic conditions. However, the overall stability in the turnover ratio suggests that Haemonetics is efficiently managing its accounts receivable collection process.

The absence of receivables turnover data for March 31, 2025, could stem from delays in financial reporting or adjustments in the company's reporting methodology. Monitoring this ratio in future periods will be crucial to assess any potential impacts on Haemonetics' cash flow and liquidity management.